280 related articles for article (PubMed ID: 15210853)
1. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.
Wang D; Luo M; Kelley MR
Mol Cancer Ther; 2004 Jun; 3(6):679-86. PubMed ID: 15210853
[TBL] [Abstract][Full Text] [Related]
2. Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector.
Yang ZZ; Chen XH; Wang D
Clin Lymphoma Myeloma; 2007 Jan; 7(4):296-304. PubMed ID: 17324338
[TBL] [Abstract][Full Text] [Related]
3. Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo.
Wang D; Zhong ZY; Li MX; Xiang DB; Li ZP
Cancer Sci; 2007 Dec; 98(12):1993-2001. PubMed ID: 17892509
[TBL] [Abstract][Full Text] [Related]
4. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
[TBL] [Abstract][Full Text] [Related]
5. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.
Ren T; Qing Y; Dai N; Li M; Qian C; Yang Y; Cheng Y; Li Z; Zhang S; Zhong Z; Wang D
Cancer Sci; 2014 Feb; 105(2):186-94. PubMed ID: 24329908
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of human apurinic/apyrimidinic endonuclease 1 by arylstibonic acids.
Seiple LA; Cardellina JH; Akee R; Stivers JT
Mol Pharmacol; 2008 Mar; 73(3):669-77. PubMed ID: 18042731
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma.
Liu Y; Zhang Z; Li Q; Zhang L; Cheng Y; Zhong Z
Oncol Rep; 2020 Aug; 44(2):499-508. PubMed ID: 32627008
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
9. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment.
Liu Y; Zhang Z; Zhang L; Zhong Z
Cell Biochem Funct; 2020 Mar; 38(2):195-203. PubMed ID: 31930546
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
12. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells.
Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D
Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133
[TBL] [Abstract][Full Text] [Related]
13. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
[TBL] [Abstract][Full Text] [Related]
14. APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.
Wen X; Lu R; Xie S; Zheng H; Wang H; Wang Y; Sun J; Gao X; Guo L
Cancer Biomark; 2016 Sep; 17(3):313-322. PubMed ID: 27802207
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro.
Xiong GS; Sun HL; Wu SM; Mo JZ
J Dig Dis; 2010 Aug; 11(4):224-30. PubMed ID: 20649735
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract][Full Text] [Related]
17. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
18. Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.
Cun Y; Dai N; Xiong C; Li M; Sui J; Qian C; Li Z; Wang D
PLoS One; 2013; 8(2):e55313. PubMed ID: 23418439
[TBL] [Abstract][Full Text] [Related]
19. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
20. Receptor-based virtual screening and biological characterization of human apurinic/apyrimidinic endonuclease (Ape1) inhibitors.
Ruiz FM; Francis SM; Tintoré M; Ferreira R; Gil-Redondo R; Morreale A; Ortiz ÁR; Eritja R; Fàbrega C
ChemMedChem; 2012 Dec; 7(12):2168-78. PubMed ID: 23109358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]